Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial
- PMID: 26164495
- PMCID: PMC4584196
- DOI: 10.1053/j.gastro.2015.06.043
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial
Abstract
We conducted an open-label crossover trial to test whether proton pump inhibitors (PPIs) affect the gastrointestinal microbiome to facilitate Clostridium difficile infection (CDI). Twelve healthy volunteers each donated 2 baseline fecal samples, 4 weeks apart (at weeks 0 and 4). They then took PPIs for 4 weeks (40 mg omeprazole, twice daily) and fecal samples were collected at week 8. Six individuals took the PPIs for an additional 4 weeks (from week 8 to 12) and fecal samples were collected from all subjects at week 12. Samples were analyzed by 16S ribosomal RNA gene sequencing. We found no significant within-individual difference in microbiome diversity when we compared changes during baseline vs changes on PPIs. There were, however, significant changes during PPI use in taxa associated with CDI (increased Enterococcaceae and Streptococcaceae, decreased Clostridiales) and taxa associated with gastrointestinal bacterial overgrowth (increased Micrococcaceae and Staphylococcaceae). In a functional analysis, there were no changes in bile acids on PPIs, but there was an increase in genes involved in bacterial invasion. These alterations could provide a mechanism by which PPIs predispose to CDI. ClinicalTrials.gov ID NCT01901276.
Keywords: Acid Suppression; Clostridium difficile Infection; Gastroesophageal Reflux Disease; Pharmacology.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health?Gastroenterology. 2015 Oct;149(4):848-50. doi: 10.1053/j.gastro.2015.08.039. Epub 2015 Aug 22. Gastroenterology. 2015. PMID: 26306767 No abstract available.
Similar articles
-
The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.mSphere. 2019 Nov 20;4(6):e00693-19. doi: 10.1128/mSphere.00693-19. mSphere. 2019. PMID: 31748246 Free PMC article.
-
Oral microbiome alterations of healthy volunteers with proton pump inhibitor.J Gastroenterol Hepatol. 2018 May;33(5):1059-1066. doi: 10.1111/jgh.14040. Epub 2018 Feb 14. J Gastroenterol Hepatol. 2018. PMID: 29105152
-
Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies.Aliment Pharmacol Ther. 2020 Mar;51(5):505-526. doi: 10.1111/apt.15604. Epub 2020 Jan 28. Aliment Pharmacol Ther. 2020. PMID: 31990420
-
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.Digestion. 2018;97(2):195-204. doi: 10.1159/000481813. Epub 2018 Jan 6. Digestion. 2018. PMID: 29316555 Review.
-
Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.Pediatrics. 2011 May;127(5):925-35. doi: 10.1542/peds.2010-2719. Epub 2011 Apr 4. Pediatrics. 2011. PMID: 21464183 Review.
Cited by
-
Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance.Biomedicines. 2024 Oct 7;12(10):2271. doi: 10.3390/biomedicines12102271. Biomedicines. 2024. PMID: 39457584 Free PMC article. Review.
-
Optimized therapeutic potential of Sijunzi-similar formulae for chronic atrophic gastritis via Bayesian network meta-analysis.EXCLI J. 2024 Sep 6;23:1185-1207. doi: 10.17179/excli2024-7618. eCollection 2024. EXCLI J. 2024. PMID: 39421026 Free PMC article.
-
New connections of medication use and polypharmacy with the gut microbiota composition and functional potential in a large population.Sci Rep. 2024 Oct 10;14(1):23723. doi: 10.1038/s41598-024-71571-4. Sci Rep. 2024. PMID: 39390025 Free PMC article.
-
Impact of proton pump inhibitors on periodontal health - A systematic review.Saudi Dent J. 2024 Sep;36(9):1160-1169. doi: 10.1016/j.sdentj.2024.07.017. Epub 2024 Aug 2. Saudi Dent J. 2024. PMID: 39286585 Free PMC article. Review.
-
Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis?Pharmaceuticals (Basel). 2024 Aug 3;17(8):1020. doi: 10.3390/ph17081020. Pharmaceuticals (Basel). 2024. PMID: 39204125 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
